What is quantum computing and how will it improve healthcare? What are the latest innovations in cell and gene therapy? How are human eating habits affected by our evolution? Health Science Radio is a podcast that answers these questions and more, exploring tomorrow’s medicine today. We talk with University of Colorado Anschutz Medical Campus researchers who are devoted to solving the most persistent challenges in health science.
This episode features a discussion about new and exciting neuroscience-based treatments that are aimed toward recovery from chronic pain. Our guest is Dr. Yoni Ashar, an assistant professor of medici…
In this episode of CU Anschutz 360, Daniel LaBarbera, PhD, director of the Center for Drug Discovery, talks about harnessing technology and innovation to speed the development of new therapies. He di…
In this episode of CU Anschutz 360, Angelo D’Alessandro, PhD, shares his fascination with blood science and how it led him into biochemistry, molecular genetics and metabolomics. A steadfast collabor…
This episode of CU Anschutz 360 focuses on the research into long COVID taking place at the University of Colorado Anschutz Medical Campus. An important study involving CU Anschutz researchers ties …
In this episode of the CU Anschutz 360 podcast, Terry Fry, MD, the inaugural executive director and Charles C. Gates Endowed Chair of the Gates Institute, explains how the institute is heading toward…
In this episode of the CU Anschutz 360 podcast, Casey Greene, PhD, the founding chair of the Department of Biomedical Informatics at the University of Colorado School of Medicine, offers insights int…
This episode of CU Anschutz 360 focuses on the Center for Combat and Battlefield Research at the University of Colorado Anschutz Medical Campus. Launched in January 2019, the COMBAT Center conducts r…
This episode of CU Anschutz 360 focuses on the mysterious and debilitating condition known as Down Syndrome Regression Disorder. DSRD is a severe neurological condition with symptoms such as loss of …
This episode of CU Anschutz 360 focuses on a promising breakthrough therapy for patients with large B-cell lymphoma, an aggressive subtype of the disease. The clinical trial was led by Manali Kamdar,…